Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Middeldorp

Showing results (321-330 of 342) with videos related to

Pageof 35
Sort By:
Research and Practice in Thrombosis and Haemostasis|April 24, 2026
Global survey of women's awareness of pregnancy- and postpartum-associated venous thromboembolism (World Thrombosis Day 2025)Marcello Di Nisio, Isabelle Mahé, Parham Sadeghipour, et al.
Frontiers in Neurology|October 8, 2024
Corrigendum: Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2020
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaborationTobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, et al.
Frontiers in Neurology|October 2, 2023
Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
Research and Practice in Thrombosis and Haemostasis|August 22, 2022
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarinIngrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf, et al.
Nature Reviews. Cardiology|March 21, 2024
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal diseaseAzita H Talasaz, Parham Sadeghipour, Luis Ortega-Paz, et al.
BMJ (Clinical Research Ed.)|October 15, 2021
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trialMichelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
Nature Reviews. Cardiology|March 11, 2026
Antiphospholipid antibodies and cardiovascular thrombosisSina Rashedi, Hannah Leyva, Saman A Siddiqui, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Heparin for Moderately Ill Patients with Covid-19Michelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.
Pageof 35

Showing results (321-330 of 342) with videos related to

Sort By:
Pageof 35
Research and Practice in Thrombosis and Haemostasis|April 24, 2026
Global survey of women's awareness of pregnancy- and postpartum-associated venous thromboembolism (World Thrombosis Day 2025)Marcello Di Nisio, Isabelle Mahé, Parham Sadeghipour, et al.
Frontiers in Neurology|October 8, 2024
Corrigendum: Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2020
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaborationTobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, et al.
Frontiers in Neurology|October 2, 2023
Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
Research and Practice in Thrombosis and Haemostasis|August 22, 2022
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarinIngrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf, et al.
Nature Reviews. Cardiology|March 21, 2024
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal diseaseAzita H Talasaz, Parham Sadeghipour, Luis Ortega-Paz, et al.
BMJ (Clinical Research Ed.)|October 15, 2021
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trialMichelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
Nature Reviews. Cardiology|March 11, 2026
Antiphospholipid antibodies and cardiovascular thrombosisSina Rashedi, Hannah Leyva, Saman A Siddiqui, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Heparin for Moderately Ill Patients with Covid-19Michelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.
Pageof 35